drug
(oxymetazoline hydrochloride + tetracaine hydrochloride)
Marketedupdated 2mo agoby St Renatus LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Apr 2, 2030
~3.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Apr 2, 2030formulationUS 85802823.7y
- Apr 2, 2030formulationUS 93081913.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that